期刊
JOURNAL OF IMMUNOLOGY
卷 184, 期 6, 页码 2949-2957出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0902151
关键词
-
类别
资金
- Austrian Science Fund [FWF P-16990]
- Medical University of Innsbruck [MFI-4301]
- Austrian Science Fund (FWF) [P 21449] Funding Source: researchfish
The pregnane X receptor (PXR) is a ligand-activated transcription factor regulating genes central to drug and hormone metabolism in the liver. Previous reports indicated that PXR is expressed in PBMC, but the role of PXR in immune cells remains unknown. In this paper, we report increased PXR expression in mouse and human T lymphocytes upon immune activation. Furthermore, pharmacologic activation of PXR inhibits T lymphocyte proliferation and anergizes T lymphocytes by decreasing the expression of CD25 and EFN-gamma and decreasing phosphorylated NF-kappa B and MEK1/2. Although these effects are preceded by an increase of suppressor of cytokine signaling 1, a master switch for IFN-gamma expression, in a PXR-dependent manner, T-bet expression remains unchanged. Conversely, PXR-deficient mice exhibit an exaggerated T lymphocyte proliferation and increased CD25 expression. Furthermore, PXR-deficient lymphocytes produce more IFN-gamma and less of the anti-inflammatory cytokine IL-10. In summary, these results reveal a novel immune-regulatory role of PXR in T lymphocytes and identify suppressor of cytokine signaling I as an early signal in PXR-mediated T lymphocyte suppression. The Journal of Immunology, 2010, 184: 2949-2957.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据